| SP-SAP Treatment for Chronic Pain...in Non-Humans |
Targeting Trends, Q3-2008 |
| ATS Licenses SP-SAP to Advanced Pain Therapeutics |
Targeting Trends, Q2-2008 |
Cato Research Ltd. and Advanced Targeting Systems, Inc.
Partner to Develop
SP-SAP for Chronic Pain |
PR
Newswire, April 3, 2008 |
| Targeted Therapy for Chronic Pain |
Targeting Trends, Q3-2007 |
| SP-SAP Drug Development Update |
Targeting Trends, Q2-2007 |
| Chronic Pain Drug - Update on SP-SAP Development |
Targeting Trends, Q2-2006 |
| SP-SAP: How It’s Different From Substance P Antagonists |
Targeting Trends, Q2-2005 |
| ATS Seeks Strategic Partner for Chronic Pain Drug |
Targeting Trends, Q1-2005 |
| Drug Development Update |
Targeting Trends, Q3-2004 |
| ATS Gets New Facility for SP-SAP Production |
Targeting Trends, Q1-2004 |
| $2.4M Drug Development Grant for SP-SAP |
Press Release Oct-2003 |
| Substance P-Saporin (SP-SAP) Drug Development Update |
Targeting Trends, Q3-2003 |
| Funding Awarded for SBIR Phase II Grant |
Targeting Trends Q1-2003 |
| Safety Studies Begin for Chronic Pain Therapeutic |
Targeting Trends Q2-2001 |
| Chronic Pain Therapeutic |
Targeting Trends Q4-2000 |
| SP-SAP as Chronic Pain Therapeutic |
Press Release Nov-1999 |
ADVANCED
TARGETING SYSTEMS